Center for Studies of Host Response to Cancer Therapy
Center for Studies of Host Response to Cancer Therapy
批准号:
10667643
负责人:
Marjan Boerma
金额:
$228.0万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-06-24 至 2025-05-31
关键词:
AddressAdverse effectsAdvisory CommitteesAffectAftercareAnimalsApplications GrantsArkansasAwardBiologicalBiomedical ResearchCancer DetectionCancer PatientCancer SurvivorCancer SurvivorshipCenters of Research ExcellenceChemotherapy and/or radiationChronicClinicalCollaborationsDedicationsDevelopmentDevelopment PlansDisciplineDose LimitingEarly DiagnosisEnsureEnvironmentExtramural ActivitiesFacultyFee-for-Service PlansFundingFunding AgencyGoalsImmune responseImmune systemIndividualInstitutionInterdisciplinary StudyLifeMalignant NeoplasmsMedicalMentorsMethodsOncologyPediatric HospitalsPhasePilot ProjectsPredispositionPreparationProcessProductivityQualifyingQuality of lifeRadiationRadiation therapyResearchResearch InfrastructureResearch InstituteResearch PersonnelResearch Project GrantsResearch SupportResourcesRoleScienceScientistSecureServicesStructureTeacher Professional DevelopmentTherapeuticTissuesToxicologyTranslational ResearchTreatment EfficacyTreatment outcomeTreatment-Related CancerTreatment-related toxicityUnited States National Institutes of HealthUniversitiesanticancer treatmentbasecancer therapycareerchemotherapycomparativedisabilityeffective interventionimprovedinterestmultidisciplinarynovel strategiespreventprogramspsychosocialrecruitresponseside effectsuccesssynergismtherapy adverse effecttranslational approachtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The objectives of the Center for Studies of Host Response to Cancer Therapy are to (1) form a self-sustaining
multidisciplinary research center within the University of Arkansas for Medical Sciences (UAMS) to increase the
understanding of mechanisms of side effects of cancer therapy, identify methods for early detection, and develop
strategies to prevent or treat such side effects and (2) help junior investigators with research programs in this
common theme establish themselves as independent scientists. Achieving these goals will create a vibrant,
multidisciplinary yet synergistic research environment. To our knowledge, few research centers focus on cancer
survivorship, and none take the paradigm-shifting approach of proactively addressing treatment-related toxicities
to improve overall cancer treatment outcomes. Specifically, this Center will provide an environment for young
investigators to succeed as independent scientists (Aim 1); strengthen the overall research infrastructure at
UAMS and the Winthrop P. Rockefeller Cancer Institute (Aim 2); and ensure that the Center becomes self-
sustaining (Aim 3). All 6 project leaders recruited to the Center in Phase 1 have built well-funded, productive
research programs and close collaborations with each other and several of the pilot project grantees. In
preparation for Phase 2, we have recruited 4 promising new/early-stage independent investigators. During Phase
1, the Center focused heavily on radiation therapy. To increase the impact and scope of the Center while
retaining its overall theme, project leaders recruited for Phase 2 have a research focus on both radiation and
chemotherapy. To increase the likelihood that project leaders will successfully secure independent extramural
research funding, individualized mentoring and faculty-development plans will be implemented, and support from
an administrative core and 2 research service cores will be integral. To replace project leaders who achieve
independence and graduate from COBRE support, a pipeline of new project leaders is ensured through
institutional support for recruiting junior faculty combined with a structured pilot project program. Strengthening
our interactions with the 5 other COBRE Centers and additional NIH-supported programs that enhance
biomedical research on the UAMS and affiliated campuses will also contribute to establishing the Center as a
self-sustaining research program that is well-integrated in the institution. The Center's progress will be guided
by highly qualified External and Internal Advisory Committees. Strong institutional support combined with active
interest from funding agencies in improving uncomplicated cancer cure rates and the quality of life of cancer
survivors ensures a high likelihood of success for the Center for Studies of Host Response to Cancer Therapy.
期刊论文(174)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide.
多西他赛,阿霉素和环磷酰胺治疗导致的认知障碍。
DOI:
10.1016/j.brainres.2021.147397
发表时间:
2021-06-01
期刊:
Brain research
影响因子:
2.9
作者:
[]
通讯作者:
DOI:
10.1016/j.bmcl.2016.03.119
发表时间:
2016-05-15
期刊:
Bioorganic & medicinal chemistry letters
影响因子:
2.7
作者:
[Joolakanti SR, Nickell JR, Janganati V, Zheng G, Dwoskin LP, Crooks PA]
通讯作者:
Crooks PA
DOI:
10.1080/09553002.2017.1231943
发表时间:
2017-03
期刊:
International journal of radiation biology
影响因子:
2.6
作者:
[Koturbash I, Merrifield M, Kovalchuk O]
通讯作者:
Kovalchuk O
DOI:
10.3390/ijms23020675
发表时间:
2022-01-08
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[Richardson KK, Ling W, Krager K, Fu Q, Byrum SD, Pathak R, Aykin-Burns N, Kim HN]
通讯作者:
Kim HN
DOI:
10.1158/0008-5472.can-20-0524
发表时间:
2020-11-01
期刊:
Cancer research
影响因子:
11.2
作者:
[Koss B, Shields BD, Taylor EM, Storey AJ, Byrum SD, Gies AJ, Washam CL, Choudhury SR, Hyun Ahn J, Uryu H, Williams JB, Krager KJ, Chiang TC, Mackintosh SG, Edmondson RD, Aykin-Burns N, Gajewski TF, Wang GG, Tackett AJ]
通讯作者:
Tackett AJ
共 118 条
Project-002
-
批准号:10355564
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2020
-
负责人:Marjan Boerma
-
依托单位:
Development of a minimally invasive biomarker assay to detect delayed radiation injury
-
批准号:10515695
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2020
-
负责人:Marjan Boerma
-
依托单位:
Development of a minimally invasive biomarker assay to detect delayed radiation injury
-
批准号:10336587
-
项目类别:
-
资助金额:$19.99万
-
财政年份:2020
-
负责人:Marjan Boerma
-
依托单位:
Development of a minimally invasive biomarker assay to detect delayed radiation injury
-
批准号:10728721
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2020
-
负责人:Marjan Boerma
-
依托单位:
Development of a minimally invasive biomarker assay to detect delayed radiation injury
-
批准号:10546448
-
项目类别:
-
资助金额:$45.35万
-
财政年份:2020
-
负责人:Marjan Boerma
-
依托单位:
Development of a minimally invasive biomarker assay to detect delayed radiation injury
-
批准号:10090564
-
项目类别:
-
资助金额:$45.92万
-
财政年份:2020
-
负责人:Marjan Boerma
-
依托单位:
Development of a minimally invasive biomarker assay to detect delayed radiation injury
-
批准号:10339340
-
项目类别:
-
资助金额:$55.76万
-
财政年份:2020
-
负责人:Marjan Boerma
-
依托单位:
The Protein C Pathway in Mitigation of Radiation-Induced Endothelial and Vascular Dysfunction
-
批准号:9384928
-
项目类别:
-
资助金额:$62.49万
-
财政年份:2017
-
负责人:Marjan Boerma
-
依托单位:
The Protein C Pathway in Mitigation of Radiation-Induced Endothelial and Vascular Dysfunction
-
批准号:10179310
-
项目类别:
-
资助金额:$58.81万
-
财政年份:2017
-
负责人:Marjan Boerma
-
依托单位:
Administrative Core
-
批准号:10487471
-
项目类别:
-
资助金额:$65.43万
-
财政年份:2015
-
负责人:Marjan Boerma
-
依托单位:
Administrative Core
-
批准号:10025388
-
项目类别:
-
资助金额:$66.88万
-
财政年份:2015
-
负责人:Marjan Boerma
-
依托单位:
Irradiation and Animal Core
-
批准号:10240507
-
项目类别:
-
资助金额:$25.84万
-
财政年份:2015
-
负责人:Marjan Boerma
-
依托单位:
Irradiation and Animal Core
-
批准号:10025390
-
项目类别:
-
资助金额:$25.84万
-
财政年份:2015
-
负责人:Marjan Boerma
-
依托单位:
Irradiation and Animal Core
-
批准号:10667654
-
项目类别:
-
资助金额:$25.84万
-
财政年份:2015
-
负责人:Marjan Boerma
-
依托单位:
Administrative Core
-
批准号:10667644
-
项目类别:
-
资助金额:$66.88万
-
财政年份:2015
-
负责人:Marjan Boerma
-
依托单位:
Administrative Core
-
批准号:10240505
-
项目类别:
-
资助金额:$66.88万
-
财政年份:2015
-
负责人:Marjan Boerma
-
依托单位:
Center for Studies of Host Response to Cancer Therapy
-
批准号:10487470
-
项目类别:
-
资助金额:$223.05万
-
财政年份:2015
-
负责人:Marjan Boerma
-
依托单位:
Center for Studies of Host Response to Cancer Therapy
-
批准号:10025387
-
项目类别:
-
资助金额:$228.0万
-
财政年份:2015
-
负责人:Marjan Boerma
-
依托单位:
Irradiation and Animal Core
-
批准号:10487476
-
项目类别:
-
资助金额:$25.28万
-
财政年份:2015
-
负责人:Marjan Boerma
-
依托单位:
Center for Studies of Host Response to Cancer Therapy
-
批准号:10240504
-
项目类别:
-
资助金额:$228.0万
-
财政年份:2015
-
负责人:Marjan Boerma
-
依托单位:
海外基金